SP11: Immunology and Vaccination Therapy

Immunological and gene therapeutic treatment approaches offer a very promising supplement to conventional therapies.
In this subproject we investigate which antigenes to which lymphoma disease at which frequency occurs.
The goal is to be able to recognize the ideal combination of tumour antigens and groups of patients for a vaccination therapy, who might benefit from an immune-therapy.
In the first project phase the Cancer-Testis-Antigene SCP-1 was already identified as a potential aspirant for the development of a vaccine against Non-Hodgkin's Lymphoma.

» Contact Persons

» Requests and Reports